Plenful has secured $50 million in Series B funding, led by Dahner Corporation's Mitchell Rales and Arena Holdings, for product development and go-to-market acceleration.

May 01, 2025•8 months ago

Amount Raised

$50 Million

Round Type

series b

San Franciscohospital & health careHealth CareSoftware

Investors

Susa/Kivu VenturesNotable CapitalTq VenturesBessemer Venture PartnersArena HoldingsMitchell RalesDahner Corporation

Description

Plenful, a workflow-automation platform for pharmacy and healthcare operations, has secured $50 million in Series B funding. This funding brings its total raise to $76 million. The funds will be used for product development and to speed up its go-to-market efforts. The round was co-led by Mitchell Rales and Arena Holdings, with participation from several other investors.

Company Information

Company

Plenful

Location

650 California Street

San Francisco, California, United States

About

Plenful is a healthcare AI-powered workflow automation platform for pharmacy and healthcare operations, streamlining manual and administrative tasks to reduce costs and drive revenue. Trusted by leading pharmacy and healthcare teams, Plenful provides highly configurable automation solutions for 340B auditing and savings identification, document data entry, inventory management, and other high ROI use-cases.

Related People

3 contacts

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends